Sun Pharma is an international, integrated, speciality pharmaceutical company with brands and branded generics in US, India and over forty markets across the world. A comprehensive product offering with technology-based differentiation are a highlight of the portfolio. Sun Pharma is the largest specialty pharmaceutical company in India with established brands across niche therapies such as psychiatry, neurology, cardiology, nephrology, gastroenterology, orthopedics and ophthalmology. In the United States of America, Sun Pharma is an integrated generic drugs company with several complex products approved for sale. Sun Pharma's API (Active Pharmaceutical Ingredients) program began in 1995 to facilitate the manufacture of complex formulations and products for which complete vertical integration would help the business. APIs are currently manufactured at nine plants, including locations in Hungary, US and Israel. Technical capabilities and dedicated sites to make complex API such as anticancers, peptides, sex hormones...